Year in Review is a unique CME activity that attempts to distill the overwhelming number of data sets and journal articles in gastrointestinal cancer published in 2009 and 2010 into a convenient summary of the most clinically relevant papers and presentations. Featuring commentary from Drs Jaffer A Ajani, Steven R Alberts, Al B Benson III, Howard S Hochster and David H Ilson. (Slide Content)
OVERVIEW OF ACTIVITY
Given the prevalent nature of the disease, extensive resources are allocated to colorectal cancer (CRC) research and education. Interestingly, however, although individually less frequently encountered, the collection of other, “non-CRC” gastrointestinal (GI) neoplasms accounts for more per annum cancer-related deaths than those attributed to tumors of the colon and rectum combined. Educational opportunities relevant to the clinical management of both CRC and non-CRC GI tumors are essential to general oncologist delivery of comprehensive cancer care. The introduction of novel biomarkers, genomic signatures and molecular-targeted systemic agents has led to a rapid paradigm shift in the clinical algorithms for these diseases that presents a challenge to practicing oncologists who must grapple with the presentation of ambiguous data sets and their immediate impact on treatment decisions. To bridge the gap between research and patient care, this CME activity uses the input of cancer experts and community physicians to frame a relevant discussion of recent research advances in GI cancers that can be applied to routine clinical practice. This information will help medical oncologists and hematology-oncology fellows formulate up-to-date clinical management strategies for patients.
LEARNING OBJECTIVES